Next Generation Sequencing Solution

Details

RFx ID :	33684009
Tender Name :	Next Generation Sequencing Solution
Reference # :	NZBS-2026-NGSS
Open Date :	Wednesday, 11 March 2026 9:00 AM (Pacific/Auckland UTC+13:00)
Close Date  :	Wednesday, 15 April 2026 5:00 PM (Pacific/Auckland UTC+12:00)
Tender Type :	Registration of Interest (ROI)
Tender Coverage :	On behalf of procurement agent  [?]
Categories :	41000000 - Laboratory and Measuring and Observing and Testing Equipment 85121800 - Medical laboratories
Regions:	New Zealand
Required Pre-qualifications :	None
Contact :	Jenna McTague jenna.mctague@nzblood.co.nz 0272378691
Alternate Physical Delivery Address  :
Alternate Physical Fax Number  :

The New Zealand Blood and Organ Service is evaluating options to upgrade its Next Generation Sequencing (NGS) platform to address the growing demand for high-resolution human leucocyte antigen (HLA) typing and cell free DNA (cfDNA) based monitoring of transplant patients. This upgrade is essential to maintain compliance with international best practice, improve turnaround times, and reduce ambiguity in transplant-related testing.
The proposed solution must be CE/IVD certified and demonstrate proven use in clinical environments for HLA typing and cfDNA analysis.